Diaceutics Fusion™ provides pharmaceutical companies and asset development teams seeking a method to develop and build in-house capabilities for co-developing and successfully commercializing targeted therapies a road tested and proven methodology, platform and route map for personalized medicine planning. Diaceutics Fusion™ can be implemented and used immediately or it can be customized and adapted to individual clients’ needs and preferences.
Diaceutics Fusion™ was built to encompass ten core principles that we have found to be indispensable to the successful co-development and commercialization of personalized therapies:
Easy to follow route maps to the 11 key frameworks and decision pathways that allow teams to easily navigate through the development lifecycle;
Access to an extensive library of case studies, data sets, personalized medicine specific worktools and financial models that illustrate the issues, risks and particulars of personalized medicine planning, allowing decisions to be made based on relevant and timely evidence;
Iterative processes and worktools that provide a facile and easy method to revisit and revise decisions as data and the commercial environment change;
Financial models and decision simulators specific to the personalized medicine space that allow teams to “try out” different decisions in a simple to use interface with rapid feedback;
Customizable and adaptable software application that allows clients to incorporate internal research and worktools into the same easy user interface;
Built-in database and access to personalized medicine experts relevant to a client’s specific personalized medicine program;
Robust personalized medicine specific project management tool where workstreams and actions are easy to identify, delegate and manage, with flags to timely remind you of impending deadlines;
Outputs and document plans that are flexible in format, easy to organize, obtain and revise and customizable to client needs;
Ongoing timely research updates and personalized medicine specific analysis to allow teams to keep up to date with the rapidly changing personalized medicine landscape.
